Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

Looking for a natural alternative to GLP-1 drugs? Integrative medicine physician Dr. Taz Bhatia has shared three foods that ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

If you can’t or don’t want to take Ozempic, your healthcare professional may recommend a different medication. Rybelsus is a glucagon-like peptide-1 (GLP-1) receptor agonist medication that ...

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and 14 other medications, a cost-saving move that would take effect in 2027. The ...

Ozempic has been approved for diabetes, though it's sometimes still used for weight loss. Rybelsus is a similar drug that's the same price and uses the same ingredient as Ozempic. But Rybelsus is a ...

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and 14 other medications, a cost-saving move that would take effect in 2027.